Javascript must be enabled to continue!
Evaluation of anti-DFS70 antibodies and DFS pattern in ANA positive individuals and ANA Associated Rheumatic Diseases
View through CrossRef
Aim: In this study we aimed to find the frequency of anti-DFS70 antibodies and DFS pattern in ANA positive individuals and ANA associated rheumatic diseases (AARDs).Methods: In this study, 337 subjects who were evaluated in a rheumatology clinic with prediagnosis of rheumatic diseases with positive ANA test and had concurrent anti-extractable nuclear antigen (anti-ENA) antibodies results were retrospectively analyzed. Clinical diagnosis of patients and demographic characteristics were obtained from the patients' medical records.Results: A total of 337 subjects (305 women, 32 men) were included in this study. The mean age was 49.8 ± 14.2 years. Of the 337 participants, 111 (32.9%) had an IIF-DFS pattern and 226 (67.1%) had a non-DFS pattern. Anti-DFS70 antibodies were positive in 20.1% of individuals. Sixty eight individuals had AARDs. An IIF-DFS pattern was observed in 22.1% and a non-DFS pattern was observed in 77.9% of individuals with AARDs (p <0.05). Anti-DFS70 antibodies were positive in 13.2% of patients with AARDs. The frequency of AARDs was significantly lower in individuals with anti-DFS70 antibodies compared to individuals with other anti-ENAs antibodies (p <0.05).Conclusion: Anti-DFS70 antibodies may be present in patients with AARDs but AARDs are less prevalent in patients who had anti-DFS70 antibodies, compared with patients who had other anti-ENAs.
Title: Evaluation of anti-DFS70 antibodies and DFS pattern in ANA positive individuals and ANA Associated Rheumatic Diseases
Description:
Aim: In this study we aimed to find the frequency of anti-DFS70 antibodies and DFS pattern in ANA positive individuals and ANA associated rheumatic diseases (AARDs).
Methods: In this study, 337 subjects who were evaluated in a rheumatology clinic with prediagnosis of rheumatic diseases with positive ANA test and had concurrent anti-extractable nuclear antigen (anti-ENA) antibodies results were retrospectively analyzed.
Clinical diagnosis of patients and demographic characteristics were obtained from the patients' medical records.
Results: A total of 337 subjects (305 women, 32 men) were included in this study.
The mean age was 49.
8 ± 14.
2 years.
Of the 337 participants, 111 (32.
9%) had an IIF-DFS pattern and 226 (67.
1%) had a non-DFS pattern.
Anti-DFS70 antibodies were positive in 20.
1% of individuals.
Sixty eight individuals had AARDs.
An IIF-DFS pattern was observed in 22.
1% and a non-DFS pattern was observed in 77.
9% of individuals with AARDs (p <0.
05).
Anti-DFS70 antibodies were positive in 13.
2% of patients with AARDs.
The frequency of AARDs was significantly lower in individuals with anti-DFS70 antibodies compared to individuals with other anti-ENAs antibodies (p <0.
05).
Conclusion: Anti-DFS70 antibodies may be present in patients with AARDs but AARDs are less prevalent in patients who had anti-DFS70 antibodies, compared with patients who had other anti-ENAs.
Related Results
DFS70 antibodies – biomarkers for the exclusion of ANA-associated autoimmune rheumatic diseases
DFS70 antibodies – biomarkers for the exclusion of ANA-associated autoimmune rheumatic diseases
Abstract
Despite the progress in the establishment of specific autoantibody assays, screening for antinuclear antibodies (ANA) by indirect immunofluorescence on HEp-...
Anti-DFS70 antibodies detected by specific methods in patients with thrombosis or recurrent pregnancy loss: no evidence of an association
Anti-DFS70 antibodies detected by specific methods in patients with thrombosis or recurrent pregnancy loss: no evidence of an association
AbstractA dense fine speckled pattern (DFS) caused by antibodies to the DFS70 kDa nuclear protein is a relatively common finding while testing for anti-nuclear antibodies (ANA) by ...
CytoBead ANA 2 assay - a novel method for the detection of antinuclear antibodies
CytoBead ANA 2 assay - a novel method for the detection of antinuclear antibodies
Abstract
Background: Detection of anti-nuclear autoantibodies (ANA) is based on a two-step algorithm including indirect immunofluorescence (IIF) on HEp2 cells and subsequen...
DFS70-Antikörper – Biomarker zum Ausschluss ANA-assoziierter rheumatischer Erkrankungen
DFS70-Antikörper – Biomarker zum Ausschluss ANA-assoziierter rheumatischer Erkrankungen
Zusammenfassung
Trotz aller Fortschritte bei der Etablierung spezifischer Autoantikörperassays ist das Screening auf antinukleäre Antikörper (ANA) mittels indirekter...
Frequency of ANA/DFS70 autoantibodies in Colombian patients with undifferentiated connective tissue disease
Frequency of ANA/DFS70 autoantibodies in Colombian patients with undifferentiated connective tissue disease
The objective was to describe the clinical characteristics and the frequency of the ANA/DFS70 autoantibodies in patients affected by undifferentiated connective tissue disease (UCT...
ANA-Specific Antibodies, ANA Patterns, Anti-ds DNA results, and Clinical Diagnosis: A Laboratory and Clinical Audit.
ANA-Specific Antibodies, ANA Patterns, Anti-ds DNA results, and Clinical Diagnosis: A Laboratory and Clinical Audit.
Abstract
Background: The diagnosis of systemic autoimmune diseases (SAID) is challenging, due to overlapping features with other non-immune disorders. Anti-nuclear ...
The Impact of Anti-HLA Antibodies on the Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome
The Impact of Anti-HLA Antibodies on the Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome
Objective To investigate the risk factors of positive anti-HLA antibodies in myelodysplastic syndrome (MDS) patients and gain insights into the impact of anti-HLA antibodies in all...
COMPARATIVO ENTRE WESTERN BLOTTING E QUIMIOLUMINESCÊNCIA (CLIA) NA DETECÇÃO DO AUTOANTICORPO ANTI-LEDGF75/DFS70 EM SOROS DE PACIENTES
COMPARATIVO ENTRE WESTERN BLOTTING E QUIMIOLUMINESCÊNCIA (CLIA) NA DETECÇÃO DO AUTOANTICORPO ANTI-LEDGF75/DFS70 EM SOROS DE PACIENTES
Objetivo: Este trabalho buscou comparar a sensibilidade e a especificidade de duas diferentes metodologias, Western Blotting por revelação colorimétrica e Quimioluminescência (CLIA...

